Gliquidone
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Excretion | 95% Biliary, 5% Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C27H33N3O6S |
| Molar mass | 527.634 g/mol |
|
WikiDoc Resources for Gliquidone |
|
Articles |
|---|
|
Most recent articles on Gliquidone |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Gliquidone at Clinical Trials.gov Clinical Trials on Gliquidone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Gliquidone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Gliquidone Discussion groups on Gliquidone Patient Handouts on Gliquidone Directions to Hospitals Treating Gliquidone Risk calculators and risk factors for Gliquidone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Gliquidone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gliquidone (INN, sold under the trade name Glurenorm®) is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2.
References
{{WikiDoc Help Menu} Template:WikiDoc Sources
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Endocrinology
- Sulfonylureas
- Drug